Neurotoxicology of the Brain Barrier System: New Implications

REFERENCES

• Davson H., Segal M. B. Physiology of the CSF and Blood-Brain Barriers. CRC Press, New York 1996
   Google Scholar
• Johanson C. E. Ventricles and Cerebrospinal Fluid. Neuroscience in Medicine, P. M. Conn. Lippincott, Philadelphia 1995; 171–196
   Google Scholar
• Karnovsky M. J. The Ultrastructural Basis of Capillary Permeability Studied with Peroxidase as a Tracer. J. Cell Biol. 1967; 35: 213–236
   PubMed Web of Science ®Google Scholar
• Bradbury M. W. The Blood-Brain Barrier. Exp. Physiol. 1993; 78: 453–472
   PubMed Web of Science ®Google Scholar
• Chandra A. M., Campbell G. A., Reddy G., Qualls C. W. Neurotoxicity of 1,3,5-Trinitrobenzene (TNB): Immunohistochemical Study of Cerebrovascular Permeability. Vet. Pathol. 1999; 36: 212–220
   PubMed Web of Science ®Google Scholar
• Romero I. A., Ray D. E., Chan M. W., Abbott N. J. An In Vitro Study of M-Dinitrobenzene Toxicity on the Cellular Components of the Blood-Brain Barrier, Astrocytes and Endothelial Cells. Toxicol. Appl. Pharmacol. 1996; 139: 94–101
   PubMed Web of Science ®Google Scholar
• Brace H., Latimer M., Winn P. Neurotoxicity, Blood-Brain Barrier Breakdown, Demyelination and Remyelination Associated with NMDA-Induced Lesions of the Rat Lateral Hypothalamus. Brain Res. Bull. 1997; 43: 447–455
   PubMed Web of Science ®Google Scholar
• Kochi S., Takanaga H., Matsuo H., Ohtani H., Naito M., Tsuruo T., Sawada Y. Induction of Apoptosis in Mouse Brain Capillary Endothelial Cells by Cyclosporin A and Tacrolimus. Life Sci. 2000; 66: 2255–2260
   PubMed Web of Science ®Google Scholar
• Abou-Donia M. B., Wilmarth K. R., Abdel-Rahman A. A., Jensen K. F., Oehme F. W., Kurt T. L. Increased Neurotoxicity Following Concurrent Exposure to Pyridostigmine Bromide, DEET, and Chlorpyrifos. Fundam. Appl. Toxicol. 1996; 34: 201–222
   PubMedGoogle Scholar
• Perl D. P., Gajdusek D. C., Garruto R. M., Yanagihara R. T., Gibbs C. J. Intraneuronal Aluminum Encephalopathy. Acta Neurophathol. 1980; 50: 19–24
   PubMedGoogle Scholar
• Banks W. A., Kastin A. J. Aluminum-Induced Neurotoxicity: Alterations in Membrane Function at the Blood-Brain Barrier. Neurosci. Biobehav. Rev. 1989; 13: 47–53
   PubMed Web of Science ®Google Scholar
• King S. W., Savory J., Wills M. R. The Clinical Biochemistry of Aluminum. CRC Crit. Rev. Clin. Lab. Sci. 1981; 14: 1–20
   Web of Science ®Google Scholar
• Aldred A. R., Brack C. M., Schreiber G. The Cerebral Expression of Plasma Protein Genes in Different Species. Comp. Biochem. Physiol. 1995; 111B: 1–15
   Web of Science ®Google Scholar
• Herbert J., Wilcox J. N., Pham K. C., Fremeau R. T., Zeviani M., Dwork A., Soprano D. R., Makover A., Goodman D. S., Zimmerman E. A., Roberts J. L., Schon E. A. Transthyretin: A Choroid Plexus-Specific Transport Protein in Human Brain. Neurology 1986; 36: 900–911
   PubMed Web of Science ®Google Scholar
• Wade S., Bleiberg-Daniel E., LeMoullac B. Rat Transthyretin: The Effects of Acute Short-Term Food Deprivation and Refeeding on the Serum and Cerebrospinal Fluid Concentration and on the Hepatic mRNA Level. J. Nutr. 1988; 118: 199–205
   PubMed Web of Science ®Google Scholar
• Ingenbleek Y., Young V. Transthyretin (Prealbumin) in Health and Disease: Nutritional Implications. Ann. Rev. Nutr. 1994; 14: 495–533
   PubMed Web of Science ®Google Scholar
• Zheng W., Lu Y. M., Lu G. Y., Zhao Q., Cheung O., Blaner W. S. Transthyretin, Thyroxin, and Retinol Binding Protein in Human Cerebrospinal Fluid: Effect of Lead Exposure. Toxicol. Sci. 2001; 61: 107–114
   PubMed Web of Science ®Google Scholar
• Zheng W., Perry D. F., Nelson D. L., Aposhian H. V. Protection of Cerebrospinal Fluid Against Toxic Metals by the Choroid Plexus. FASEB J. 1991; 5: 2188–2193
   PubMed Web of Science ®Google Scholar
• Zheng W., Shen H., Blaner S. B., Zhao Q., Ren X., Graziano J. H. Chronic Lead Exposure Alters Transthyretin Concentration in Rat Cerebrospinal Fluid: The Role of the Choroid Plexus. Toxicol. Appl. Pharmacol. 1996; 139: 445–450
   PubMed Web of Science ®Google Scholar
• Zheng W., Blaner W. S., Zhao Q. Inhibition by Pb of Production and Secretion of Transthyretin in the Choroid Plexus: Its Relationship to Thyroxine Transport at the Blood-CSF Barrier. Toxicol. Appl. Pharmacol. 1999; 155: 24–31
   PubMed Web of Science ®Google Scholar
• Dussault J. H., Ruel J. Thyroid Hormones and Brain Development. Ann. Rev. Physiol. 1987; 49: 321–334
   PubMed Web of Science ®Google Scholar
• Legrand J. Effect of Thyroid Hormones on Central Nervous System Development. Neurobehavioral Teratology, J. Yanai. Elsevier, New York 1984; 331–363
   Google Scholar
• Smith D. W., Blizzard R. M., Wilkins L. The Mental Prognosis in Hypothyroidism of Infancy in Childhood. Pediatrics 1957; 19: 1011–1022
   PubMed Web of Science ®Google Scholar
• Kalaria R. N., Mitchell M. J., Harik S. I. Correlation of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity with Blood-Brain Barrier Monoamine Oxidase Activity. Proc. Natl. Acad. Sci. USA 1987; 84: 3521–3525
   PubMed Web of Science ®Google Scholar
• Riachi N. J., Behmand R. A., Harik S. I. Correlation of MPTP Neurotoxicity In Vivo with Oxidation of MPTP by the Brain and Blood-Brain Barrier In Vitro in Five Rat Strains. Brain Res. 1991; 555: 19–24
   PubMed Web of Science ®Google Scholar
• Strazielle N., Ghersi-Egea J. F. Demonstration of a Coupled Metabolism-Efflux Process at the Choroid Plexus as a Mechanism of Brain Protection Toward Xenobiotics. J. Neurosci. 1999; 19: 6275–6289
   PubMed Web of Science ®Google Scholar
• Nagahiro S., Yamamoto Y. L., Diksic M., Mitsuka S., Sugimoto S., Feindel W. Neurotoxicity After Intracarotid 1,3-Bis(2-Chloroethyl)-1-nitrosourea Administration in the Rat: Hemodynamic Changes Studied by Double-Tracer Autoradiography. Neurosurgery 1991; 29: 19–25
   PubMed Web of Science ®Google Scholar
• Szumanska G., Gadamski R., Albrecht J. Changes of the Na/K ATPase Activity in the Cerebral Cortical Microvessels of Rat After Single Intraperitoneal Administration of Mercuric Chloride: Histochemical Demonstration with Light and Electron Microscopy. Acta Neuropathol. 1993; 86: 65–70
   PubMed Web of Science ®Google Scholar
• Mooradian A. D. Effect of Aging on the Blood-Brain Barrier. Neurobiol. Aging 1988; 9: 31–39
   PubMed Web of Science ®Google Scholar
• Raven J. R. Vascular Changes in the Human Senile Brain. Adv. Neurol. 1970; 20: 487–501
   Google Scholar
• Ellis R. J., Olichney J. M., Thal L. J., Mirra S. S., Morris J. C., Beekly D., Heyman A. Cerebral Amyloid Angiopathy in Brains of Patients with Alzheimer's Disease: The CERAD Experience, Part XV. Neurology 1996; 46: 1592–1596
   PubMed Web of Science ®Google Scholar
• Walker L. C. Animal Models of Cerebral β-Amyloid Angiopathy. Brain Res. Rev. 1997; 25: 70–84
   PubMed Web of Science ®Google Scholar
• Miklossy J., Taddei K., Martins R., Escher G., Kraftsik R., Pillevuit O., Lepori D., Campiche M. Alzheimer's Disease: Curly Fibers and Tangles in Organs Other Than Brain. J. Neuropathol. Exp. Neurol. 1999; 58: 803–814
   PubMed Web of Science ®Google Scholar
• Moore P., White J., Christiansen V., Grammas P. Protein Kinase C-Zeta Activity but Not Level Is Decreased in Alzheimer's Disease Microvessels. Neurosci. Lett. 1998; 254: 29–32
   PubMed Web of Science ®Google Scholar
• Hampel H., Kotter H. U., Padberg F., Korschenhausen D. A., Moller H. J. Oligoclonal Bands and Blood Cerebrospinal-Fluid Barrier Dysfunction in a Subset of Patients with Alzheimer's Disease: Comparison with Vascular Dementia, Major Depression, and Multiple Sclerosis. Alzheimer Dis. Assoc. Disorders 1999; 13: 9–19
   PubMed Web of Science ®Google Scholar
• Laterra J., Bressler J. P., Indurti R. R., Belloni-Olivi L., Goldstein G. W. Inhibition of Astroglia-Induced Endothelial Differentiation by Inorganic Lead: A Role for Protein Kinase C. Proc. Natl. Acad. Sci. USA 1992; 89: 10748–10752
   PubMed Web of Science ®Google Scholar
• Zhao Q., Slavkovich V., Zheng W. Lead Exposure Promotes Translocation of Protein Kinase C Activity in Rat Choroid Plexus In Vitro, But Not In Vivo. Toxicol. Appl. Pharmacol. 1998; 149: 99–106
   PubMed Web of Science ®Google Scholar
• Glenner G., Wong W. Alzheimer's Disease: Initial Report of the Purification and Characterization of a Novel Cerebrovascular Amyloid Protein. Biochem. Biophys. Res. Commun. 1984; 120: 885–890
   PubMed Web of Science ®Google Scholar
• Joachim C. L., Mori H., Selkoe D. J. Amyloid Beta Protein Deposition in Tissues Other Than Brain in Alzheimer's Disease. Nature 1989; 341: 226–230
   PubMed Web of Science ®Google Scholar
• Weidemann A., Konig G., Bunke D., Fischer P., Salbaum J. M., Masters C. L., Beyreuther K. Identification, Biogenesis, and Localization of Precursors of Alzheimer's Disease A4 Amyloid Protein. Cell 1989; 57: 115–126
   PubMed Web of Science ®Google Scholar
• Ghersi-Egea J. F., Gorevis P. D., Ghiso J., Frangione B., Patlak C. S., Fenstermacher J. D. Fate of Cerebrospinal Fluid-Borne Amyloid β-Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral Arteries. J. Neurochem. 1996; 67: 880–883
   PubMed Web of Science ®Google Scholar
• Shirahama T., Skinner M., Westermark P., Rubinow A., Cohen A. S., Brun A., Kemper T. L. Senile Cerebral Amyloid. Prealbumin as a Common Constituent in the Neuritic Plaque, in the Neurofibrillary Tangle, and in the Microangiopathic Lesion. Am. J. Pathol. 1982; 107: 41–50
   PubMed Web of Science ®Google Scholar
• Schwarzman A. L., Gregori L., Vitek M. P., Lyubski S., Strittmatter W. J., Enghilde J. J., Bhasin R., Silverman J., Weisgraber K. H., Coyle P. K., Zagorski M. G., Talafous J., Eisenberg M., Saunders A. M., Roses A. D., Goldgaber D. Transthyretin Sequesters Amyloid β Protein and Prevents Amyloid Formation. Proc. Natl. Acad. Sci. USA 1994; 91: 8368–8372
   PubMed Web of Science ®Google Scholar
• Mazur-Kolecka B., Frackowiak J., Carroll R. T., Wisniewski H. M. Accumulation of Alzheimer Amyloid-β Peptide in Cultured Myocytes Is Enhanced by Serum and Reduced by Cerebrospinal Fluid. J. Neuropath. Exp. Neurol. 1997; 56: 263–272
   PubMed Web of Science ®Google Scholar
• Riisoen H. Reduced Prealbumin (Transthyretin) in CSF of Severely Demented Patients with Alzheimer's Disease. Acta Neurol. Scand. 1988; 78: 455–459
   PubMed Web of Science ®Google Scholar
• Serot J. M., Christmann D., Dubost T., Couturier M. Cerebrospinal Fluid Transthyretin: Aging and Late Onset Alzheimer's Disease. J. Neurol. Neurosurg. Psych. 1997; 63: 506–508
   PubMed Web of Science ®Google Scholar
• Serot J. M., Bene M. C., Foliguet B., Faure G. C. Altered Choroid Plexus Basement Membrane and Epithelium in Late-Onset Alzheimer's Disease: An Ultrastructural Study. Ann. New York Acad. Sci. 1997; 826: 507–509
   PubMedGoogle Scholar
• Zheng W., Zhao Q., Slavkovich V., Aschner M., Graziano H. Alteration of Iron Homeostasis Following Chronic Exposure to Manganese in Rats. Brain Res. 1999; 833: 125–132
   PubMed Web of Science ®Google Scholar
• Connor J. R., Benkovic S. A. Iron Regulation in the Brain: Histochemical, Biochemical, and Molecular Considerations. Ann. Neurol. 1992; 32(Suppl)S51–S61
   PubMedGoogle Scholar
• Jefferies W. A., Brandon M. R., Hunt S. V., Williams A. F., Gatter K. C., Mason D. Y. Transferrin Receptor on Endothelium of Brain Capillaries. Nature 1984; 312: 162–163
   PubMed Web of Science ®Google Scholar
• Zheng W. Toxicology of Choroid Plexus: A Special Reference to Metal-Induced Neurotoxicities. Microsc. Res. Tech. 2001; 52: 89–103
   PubMed Web of Science ®Google Scholar
• Zheng W., Ren S., Graziano J. H. Manganese Inhibits Mitochondrial Aconitase: A Mechanism of Manganese Neurotoxicity. Brain Res. 1998; 799: 334–342
   PubMed Web of Science ®Google Scholar
• Jenner P., Schapira A. H., Marsden C. D. New Insights into the Cause of Parkinson's Disease. Neurology 1992; 42: 2241–2250
   PubMed Web of Science ®Google Scholar
• Youdim M. B.H., Ben-Shachar D., Riederer P. The Possible Role of Iron in the Etiopathology of Parkinson's Disease. Mov. Disorders 1993; 8: 1–12
   PubMed Web of Science ®Google Scholar
• Epstein L. G., Gendelman H. E. Human Immunodeficiency Virus Type 1 Infection of the Nervous System: Pathogenetic Mechanisms. Ann. Neurol. 1993; 33: 429–436
   PubMed Web of Science ®Google Scholar
• Price R. W., Brew B., Sidtis J., Rosenblum M., Scheck A. C., Cleary P. The Brain in AIDS: Central Nervous System HIV-1 Infection and AIDS Dementia Complex. Science 1988; 239: 586–592
   PubMed Web of Science ®Google Scholar
• Blumberg B. M., Gelbard H. A., Epstein L. G. HIV-1 Infection of the Developing Nervous System: Central Role of Astrocytes in Pathogenesis. Virus Res. 1994; 32: 253–267
   PubMed Web of Science ®Google Scholar
• Falangola M. F., Petito C. K. Choroid Plexus Infection in Cerebral Toxoplasmosis in AIDS Patients. Neurology 1993; 43: 2035–2040
   PubMed Web of Science ®Google Scholar
• Harouse J. M., Wroblewska Z., Laughlin M. A., Hickey W. F., Schonwetter B. S., Gonzalez-Scarano F. Human Choroid Plexus Cells Can Be Latently Infected with Human Immunodeficiency Virus. Ann. Neurol. 1989; 25: 406–411
   PubMed Web of Science ®Google Scholar
• Power C., Johnson R. T. HIV-1 Associated Dementia: Clinical Features and Pathogenesis. Can. J. Neurol. Sci. 1995; 22: 92–100
   PubMed Web of Science ®Google Scholar
• Rudin D. O. Covert Transport Dysfunction in the Choroid Plexus as a Possible Cause of Schizophrenia. Schizophr. Bull. 1979; 5: 623–626
   PubMed Web of Science ®Google Scholar
• Levine S. Choroid Plexus: Target for Systemic Disease and Pathway to the Brain. Lab. Invest. 1987; 56: 231–233
   PubMed Web of Science ®Google Scholar
• Jorgensen O. S. Neural Cell Adhesion Molecule (NCAM) and Prealbumin in Cerebrospinal Fluid from Depressed Patients. Acta Psychiatr. Scand. (Suppl). 1988; 345: 29–37
   Google Scholar
• Sullivan G. M., Hatterer J. A., Herbert J., Chen X., Roose S. P., Attia E., Mann J. J., Marangell L. B., Goetz R. R., Gorman J. M. Low Levels of Transthyretin in the CSF of Depressed Patients. Am. J. Psychiatr. 1999; 156: 710–715
   PubMed Web of Science ®Google Scholar
• Ormerod W. E., Venkatesan S. The Choroid Plexus in African Sleeping-Sickness. Lancet 1970; 2(676)777
   PubMedGoogle Scholar
• Campbell J. B., Woolley D. E., Vijayan V. K., Overmann S. R. Morphometric Effects of Postnatal Lead Exposure on Hippocampal Development of the 15-Day-Old Rat. Brain Res. 1982; 255: 595–612
   PubMed Web of Science ®Google Scholar
• Slomianka L., Rungby J., West M. J., Danscher G., Andersen A. H. Dose-Dependent Bimodal Effect of Low-Level Lead Exposure on the Developing Hippocampal Region of the Rat: A Volumetric Study. Neurotoxicology 1989; 10: 177–190
   PubMed Web of Science ®Google Scholar
• Friedheim E., Corvi C., Graziano J., Donnelli T., Breslin D. Choroid Plexus as Protective Sink for Heavy Metals?. Lancet 1983, 8331: 981–982
   PubMed Web of Science ®Google Scholar
• Saunders N. R. Ontogeny of the Blood-Brain Barrier. Exp. Eye Res. 1977; 25(Suppl)523–550
   PubMedGoogle Scholar
• Schultze C., Firth J. A. Interendothelial Junctions During Blood-Brain Barrier Development in the Rat. Dev. Brain Res. 1992; 69: 85–95
   Web of Science ®Google Scholar
• Hayashi Y., Nomura M., Yamagishi S., Harada S., Yamashita J., Yamamoto H. Induction of Various Blood-Brain Barrier Properties in Nonneural Endothelial Cells by Close Apposition to Co-Cultured Astgrocytes. Glia 1997; 19: 13–26
   PubMed Web of Science ®Google Scholar
• Nishino H., Kumazaki M., Fukuda A., Fujimoto I., Shimano Y., Hida H., Sakurai T., Deshpande S. B., Shimizu H., Morikawa S., Inubushi T. Acute 3-Nitropropionic Acid Intoxication Induces Striatal Astrocytic Cell Death and Dysfunciton of the Blood-Brain Barrier: Involvement of Dopamine Toxicity. Neurosci. Res. 1997; 27: 343–355
   PubMed Web of Science ®Google Scholar